- Home
- FOXX vs DYAI Comparison
FOXX vs DYAI Comparison
Compare FOXX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOXX | DYAI |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 17.0M |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FOXX | DYAI |
|---|---|---|
| Price | $2.00 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.9K | ★ 106.1K |
| Earning Date | 11-17-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,584,432.00 | $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.71 | $0.34 |
| 52 Week High | $7.90 | $1.60 |
Technical Indicators
Market Signals| Indicator | FOXX | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.71 | 36.80 |
| Support Level | N/A | $0.34 |
| Resistance Level | $2.77 | $0.49 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 10.64 | 30.95 |
Price Performance
Historical ComparisonAbout FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.